Skip to Content


MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

International Parkinson and Movement Disorder Society
Main Content

MDS- ES Pump-based Therapies in Advanced Parkinson´s Disease

MDS-Africa Mouvements Anormaux (Abnormal Movements) – Presented in French

Lectures and associated resources available August 25, 2021



Course Directors

David Devos, Anna Sauerbier, and Per Odin


To be announced.

Course Description

This course will provide knowledge about the neuropharmacological basis of treatment of advanced Parkinson´s disease (APD). It will also give a theoretical and practical education in the indication and the management of pump-based treatments for APD (including Levodopa-carbidopa intestinal gel, Levodopa-carbidopa entacapone intestinal gel and apomorphine). The course includes lectures on neuropharmacology, experimental basis of continuous dopaminergic stimulation (past, current and future treatments), history, patient selection, effects, side effects and practical management, as well as, interactive workshops on patient selection and choice of advanced therapy. An emphasis will also be case-based presentations.

Interactive Components

Lectures will be streamed live to participants on the days of the course. In addition to the didactic lectures, faculty will lead interactive workshops concerning patient selection and choice of advanced therapies. Faculty will also presenting interactive case based presentations.

Target Audience

This course is intended for Basic Science Researchers, Translational Researchers, Clinical Researchers, Clinical Nurse Specialists, Physio / Physical Therapists, and Occupational Therapists

Learning Objectives 
  1. Describe the neuropharmacological background for treatment of advanced Parkinson´s disease, including the relevance of continuous dopaminergic stimulation-based treatment

  2. Define the criteria and process for selecting the ideal patients for advanced Parkinson’s disease therapy through therapy comparison for a balanced outlook

  3. Compare the effects of pump treatment on motor and non-motor symptoms, quality of life, and the real-life based safety aspects of these therapies

  4. Demonstrate practical handling of pump-based therapies

  5. Plan a unit for pump-based therapies – what is needed?